搜索
Immunoprecise Antibodies Ltd
IPA添加自选
2.070USD
0.0000.00%
收盘 07/02, 13:00（美东）报价延迟15分钟
95.54M总市值
亏损市盈率 TTM
关于 Immunoprecise Antibodies Ltd 公司
ImmunoPrecise Antibodies Ltd. 是一家生物技术公司，通过一系列专有和专利技术利用多组学建模和复杂人工智能。该公司拥有一套集成的端到端功能来支持治疗性抗体的开发。它在北美和欧洲拥有多家子公司，包括 Talem Therapeutics LLC、BioStrand BV、ImmunoPrecise Antibodies (Canada) Ltd. 和 ImmunoPrecise Antibodies (Europe) BV（统称为 IPA 家族）等实体。其合同研究组织 (CRO) 服务包括 B 细胞选择；噬菌体展示；DeepDisplay；Abthena 双特异性；LucinaTech 人性化；亲和力成熟；免疫、杂交瘤、测序；rPEx 蛋白质制造和细胞系开发。该公司利用定制抗原建模、使用自然语言处理的靶标分析和 HYFTTM 分析为后续实验阶段奠定基础。
Immunoprecise Antibodies Ltd简介
公司代码IPA
公司名称Immunoprecise Antibodies Ltd
上市日期Jan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.
员工数量- -
证券类型Ordinary Share
年结日Jan 30
公司地址Industrious 823 Congress Ave Suite 300
城市AUSTIN
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编78701
电话16048060626
网址https://www.ipatherapeutics.com/
公司代码IPA
上市日期Jan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.
Immunoprecise Antibodies Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Shuji Sato
Dr. Shuji Sato
Vice President - Innovative Solutions
Vice President - Innovative Solutions
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
常见问题
Immunoprecise Antibodies Ltd的前五大股东是谁？
Immunoprecise Antibodies Ltd 的前五大股东如下：Dr. Jennifer Lynne Bath, Ph.D.
有多少机构持有Immunoprecise Antibodies Ltd(IPA)的股份？
截至2026Q1，共有47家机构持有Immunoprecise Antibodies Ltd的股份，合计持有的股份价值约为4.54M，占公司总股份的9.73%。与2025Q4相比，机构持股有所增加，增幅为212280.00。
哪个业务部门对Immunoprecise Antibodies Ltd的收入贡献最大？
在2026Q1，Project revenue业务部门对Immunoprecise Antibodies Ltd的收入贡献最大，创收4.11M，占总收入的98.85%。